Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report

被引：10
|
作者：
Bourkas, Adrienn N. [1 ,2 ,4 ]
Sibbald, Cathryn [2 ,3 ]
机构：
[1] Queens Univ, Sch Med, Kingston, ON, Canada
[2] Hosp Sick Children, Dept Paediat, Div Dermatol, Toronto, ON, Canada
[3] Univ Toronto, Dept Med, Div Dermatol, Toronto, ON, Canada
[4] Queens Univ, Sch Med, Kingston, ON K7L 3N6, Canada
来源：
SAGE OPEN MEDICAL CASE REPORTS | 2022年 / 10卷
关键词：
Alopecia areata; atopic dermatitis; Janus kinase inhibitors; hair diseases; skin diseases;
D O I：
10.1177/2050313X221138452
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This case report describes the first successful treatment of alopecia areata and atopic dermatitis with the Janus kinase 1 inhibitor upadacitinib in a paediatric patient. After minimal response to topical corticosteroids and spironolactone, improvements in hair growth on the scalp and body were noted after only 6 weeks of upadacitinib treatment.
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Upadacitinib improved alopecia areata in a patient with atopic dermatitis: A case report
    Cantelli, Mariateresa
    Martora, Fabrizio
    Patruno, Cataldo
    Nappa, Paola
    Fabbrocini, Gabriella
    Napolitano, Maddalena
    DERMATOLOGIC THERAPY, 2022, 35 (04)
  • [2] Dual efficacy of upadacitinib in a patient with concomitant severe atopic dermatitis and alopecia areata
    Walls, B.
    Reguiai, Z.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2023, 150 (04): : 281 - 283
  • [3] UPADACITINIB IN CONCURRENT SEVERE ATOPIC DERMATITIS, ALOPECIA AREATA AND CROHN'S DISEASE: A CASE REPORT
    Novielli, D.
    Foti, C.
    Principi, M. B.
    Romita, P.
    Dell'Aquila, P.
    Mortato, E.
    Di Leo, A.
    Ambrogio, F.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S236 - S236
  • [4] Upadacitinib in concurrent Crohn's disease, atopic dermatitis and alopecia areata: A case report
    Novielli, D.
    Foti, C.
    Principi, M.
    Mortato, E.
    Romita, P.
    Dell'Aquila, P.
    Di Leo, A.
    Ambrogio, F.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (01) : E8 - E10
  • [5] Concurrent chronic alopecia areata and severe atopic dermatitis successfully treated with upadacitinib
    Asfour, Lella
    Getsos Colla, Themis
    Moussa, Anthony
    Sinclair, Rodney D.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (11) : E416 - E417
  • [6] Upadacitinib for the treatment of alopecia areata - A case report
    Yeh, Jui-Wen
    Yang, Chao-Chun
    DERMATOLOGICA SINICA, 2024, 42 (02)
  • [7] Dupilumab Improved Alopecia Areata in a Patient with Atopic Dermatitis: A Case Report
    Uchida, Hideaki
    Kamata, Masahiro
    Watanabe, Ayu
    Agematsu, Ai
    Nagata, Mayumi
    Fukaya, Saki
    Hayashi, Kotaro
    Fukuyasu, Atsuko
    Tanaka, Takamitsu
    Ishikawa, Takeko
    Ohnishi, Takamitsu
    Tada, Yayoi
    ACTA DERMATO-VENEREOLOGICA, 2019, 99 (07) : 675 - 676
  • [8] Selective JAK 1 inhibition with upadacitinib as a potential treatment for coexistent severe atopic dermatitis and alopecia areata
    Muzy, Guilherme
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2024, 99 (03) : 483 - 484
  • [9] Dual Efficacy of Upadacitinib in 2 Patients With Concomitant Severe Atopic Dermatitis and Alopecia Areata
    Gambardella, Alessio
    Licata, Gaetano
    Calabrese, Giulia
    De Rosa, Alina
    Alfano, Roberto
    Argenziano, Giuseppe
    DERMATITIS, 2021, 32 (1S) : E85 - E86
  • [10] Hair repigmentation and regrowth in a dupilumab-treated paediatric patient with alopecia areata and atopic dermatitis: a case report
    Yan, Xin
    Tayier, Munire
    Cheang, Sin Tong
    Liao, Zhongmin
    Dong, Yi
    Yang, Yifeng
    Ye, Yanting
    Zhang, Xingqi
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2023, 14
12345